Insights

  • Date

  • Content Type

  • Reset

Article

Five marketing strategies for novel therapeutics

8.12.21
By Christian K Schneider

Long before the advent of Coronavirus, next-generation therapies were making headlines, but the successful development of...
Read More

Article

Marketing strategies for next-gen therapies

2.12.21
By Christian K Schneider

The successful development of COVID-19 vaccines, including mRNA vaccines, has shone a spotlight on next-generation therapies...
Read More

Video

Meeting on the Mesa 2021 | Impact of COVID-19 on the advanced therapies sector

2.12.21

By Christian Schneider, MD


Christian discusses the effects of the COVID-19 pandemic on the advanced therapies sector

Read More

Blog

Roadmap to commercialization success: Build agility into drug development plans

29.11.21

By Dr. Diane Seimetz

We know the lifechanging impact that gene, cell and tissue-based therapies..

Read More

Blog

The new economics of innovative therapies: Navigating emerging payment models

11.11.21

By Alberto Rubio

For years, market access strategies for new therapies almost exclusively depended on data supporting efficacy and safety. ..

Read More

Article

Designing Vaccines: The Role of Artificial Intelligence and Digital Health, Part 1

9.11.21
By Aleksandra Nevmerzhitskaya

According to the founder and executive chairman of the World Economic Forum, Klaus Schwab
Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more